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Abstract 
Tuberculosis and human Immuno-deficiency virus co-epidemics remain a major public health 
challenge particularly in resource limited settings. This study determined the prevalence of HIV 
co-infection among TB patients and the risk factors among patients attending Holly memorial 
Hospital Ochadamu, Ofu L.G.A., Kogi State, Nigeria. Two hundred (200) patients participated in 
the research, out of which one hundred and seventy three (173) were already confirmed to be 
HIV positive. Sputum samples were collected by experts into sample bottles aseptically for Acid 
fast Bacilli test for Mycobacterium tuberculosis; while blood samples were collected by trained 
nurses from the same candidates by venepuncture into anticoagulated bottles for HIV screening 
to re- confirm their status. Questionnaires were also administered to obtain some important 
demographic data. Sputum smear microscopy was carried out to test for Acid Fast Bacilli. Rapid 
haemagglutination assay was carried out to re-confirm the HIV status of the patients. Results 
showed that Twenty seven (27) patients signifying 13.5 % were TB/HIV co-infected. There was 
significant (p<0.05) relationship between TB and HIV status of the patients and clinical 
symptoms (dry cough, cough with sputum, weight loss and fever). There is need to study 
Immuno-haematological indices (CD4 count, Full Blood Count and ESR) routinely to monitor 
TB and HIV patients on regular basis in order to reduce morbidity and mortality associated with 
the diseases. 
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1. Introduction 
 
Tuberculosis (TB) and human immunodeficiency virus (HIV) co-epidemics remain a major 
public health challenge, particularly in resource limited settings (Tadess et al., 2013). There were 
an estimated 1.1 million TB/HIV co-Infected patients worldwide in 2011, 79% of those cases 
were in Africa (WHO, 2012). There has been a strong link between tuberculosis (TB) and HIV, 
as they are both capable of disarming the host’s immune responses. TB is the most common 
opportunistic disease which kills those infected with HIV (Modjarrad and Vermund., 2010). HIV 
co-infection also increases the risk of latent TB reactivation by 20-fold, and is the most powerful 
known risk factor for progression of Mycobacterium tuberculosis infection to active disease 
(Getahum et al., 2010; Kwan and Ernst, 2011). In Nigeria, the majority of TB infections are 
caused by M. tuberculosis followed by M. africanum and M. bovis, and most importantly, the 
burden of the disease is the highest in Africa. Nigeria ranks top in Africa with respect to the 
burden of both TB and HIV infections. In 2007, the estimated proportion of TB cases that were 
coinfected with HIV was 27% (Dim, 2012). 
  
To improve the diagnostic and intervention outcomes for TB/HIV co-Infection patients, world 
health organization (WHO) developed a framework of strategic collaborative activities to be 
performed as parts of health sector response to control co-epidemic (WHO, 2004). .  
  
Furthermore, the global effort at controlling the disease through the Stop TB initiative has been 
seriously challenged by the human immunodeficiency virus (HIV) pandemic in developing 
countries. This is because, TB is associated with HIV infection; HIV-positive individuals are 
about 20 to 37 times more likely to develop TB when compared to HIV-negative individuals. 
Likewise, a TB patient who is coinfected with HIV (TB/HIV) is more likely to die, and when 
sputum positive (ss+), is more likely to transmit the infection (Dim, 2012). 
 
Knowledge about HIV co-infection status among TB patients might help understand the spread 
of the dual infection and to monitor the performances of TB and HIV control activities (WHO, 
2012).   
 
This study determined the prevalence and risk factors of HIV co-Infection among Tuberculosis 
patients attending Holley Memorial Hospital Ochadamu, Ofu Local Government Area, Kogi 
State.  
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2. Materials and Methods 
 
2.1. Study Area and Population  
 
This study was carried out at Holley Memorial Hospital, Ochadamu, Ofu L.G.A, Kogi state. 
Kogi State is located in the central belt of Nigeria on Latitude 7
o48’ 0”N and Longitude 6o 44’ 
0”E. The people have a mixed culture with farming as their major occupation. The hospital was 
founded as a Non-Governmental Organization (NGO) in 1950 by the Qua Iboe fellowship, a 
local Nigerian church in response to the needs of those suffering from leprosy in Nigeria. HMH 
is recognized by the Nigerian Government as a place of excellence in the treatment of Leprosy 
and Tuberculosis. The Department is run in partnership with the Leprosy mission international. 
Today however, the hospital has grown to be a large general hospital providing specialist 
services in surgery, maternity and obstetrics, orthopaedics, ophthalmics and caring for an 
increasing number of people suffering from TB and HIV/AIDS. A large out patients Department 
cares for the growing local population. 
 
2.2. Inclusion/Exclusion Criteria  
 
The inclusion criteria for the study subjects were HIV infected patients receiving antiretroviral 
treatment at the Holley Memorial Hospital Ochadamu during the period of the study (January to 
October 2015) who gave informed consent to participate in the study. The population groups 
covered during the study was adult men and women attending antiretroviral control (ARC) in the 
hospital. It is pertinent to mention that those healthy adult are the reproductive group and are 
therefore a good proxy for the general population in the determination of the prevalence of TB, 
HIV and TB/HIV coinfection. Patients that were too sick and unable to communicate were 
excluded from the study.  
 
2.3. Sample Collection  
 
Blood sample was collected from patients and transferred into an ethylene diamine-tetraacetric 
acid (EDTA) for HIV test, while sputum samples were obtained from each patient, thus each 
patient produced two sputum sample within an hour interval.  
 
2.4. HIV Test  
 
HIV test was carried out using rapid test kit Determine 
(R)
 (manufactured by Alere, San Dio. 
Callifonia)  Start pack was used as confirmatory test.  
 
Samples are collected from patients through venepuncture. The blood sample is centrifuged at 
1500 rpm for 5 minutes to prepare the serum. HIV screening was carried out according to 
manufacturers’ manual.  
 
2.5. AFB Test  
 
TB diagnosis was made based on the findings of acid fast bacilli by Zielneelson (ZN) staining. 
Sputum specimen we decontaminated by modified Petroff’s methods using sodium hydroxide 
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(NaOH) and then concentrated by centrifugation at 3000rpm for 15 minutes. After centrifugation 
it was examined by microscopy.  
 
2.6. Statistical Analysis  
 
Complete questionnaire were coded by numbers and entered in a computer software excel cross-
checking and data cleaning was done the data was then transferred to statistical package for 
social science version 16 (Spss Inc Chicago, USA) and graph pad prism 5 for analysis. Chi-
square test was used to test for differences in proportions. Student test was used to test for 
differences in means between two or more groups. All statistical test were considered significant 
if the two sided P-value (p) was <0.05 
 
3. Results 
 
Age Distribution of TB/HIV Co-infected Patients Attending Holley Memorial Hospital 
Ochadamu  
 
Age distribution of TB/HIV co-infected patients attending Holley memorial hospital showed that 
out the 200 patients, 27 (13.5%) patients are TB/HIV co-infected (Table 1). Age group 21-years 
recorded coinfection rate of 4-5%. 
 
Table 1:  Age distribution of TB/HIV Co-infected Patients Attending Holley Memorial Hospital 
Ochadamu  
Age  No of respondents            No positive   Prevalence % 
0-10 12                 0  0.0 
11-20 22                 4  2.0 
21-30 51                 8  4.0 
31-40 67                10  5.0 
41-50 27                 2  1.0 
51-60 13                 1  0.5 
61-70 4                 1  0.5 
71-80 4                 1  0.5 
81-90 00                 00  0.0 
91-100 00                 00  0.0 
Total  200                27  13.5 
 
X
2
 cal = 7; α = 0.05; P = 0.00l   
 
Gender Distribution of HIV/TB Co-infected Patients Attending Holley Memorial Hospital 
Ochadamu 
   
Gender distributions of TB/HIV coinfected patients showed that 16 (8.0%) male are TB/HIV 
coinfected while 11(5.5%) female are TB/HIV coinfected (Table 2).  
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Table 2: Gender Distribution of HIV/TB coinfected patients attending Holley memorial hospital 
ochadamu 
Gender  No of respondents  No positive  No negative  Prevalence % 
Male  85 16 69 8.0 
Female  115 11 104 5.5 
Total  200 27 173 13.5 
X
2
 tab = 1.005; P =0.00001; α= 0.05. 
 
Distribution of TB/HIV Coinfection among Patients Attending Holley Memorial Hospital 
Based on their Marital Status  
  
On the basis of marital status, 14 (18.2%) were single, 12 (10.3%) were married, 1 (3.3%) 
divorced (Table 3).  
 
Table 3: Distribution of TB/HIV coinfection among patients attending Holley Memorial Hospital 
based on their marital status 
Marital status No of respondents  No positive  No negative  Prevalence % 
Single  77 14 63 18.2 
Married  117 12 105 10.3 
Widow/widower 1 0 1 0.0 
Divorced  3 1 2 3.3 
Separated  2 0 2 0.0 
Total  200 27 173 13.5 
X
2
 = 4.05; p =0.0001; α = 0.005.  
 
Educational Status of TB/HIV Co-infected Persons Attending Holley Memorial Hospital 
Ochadamu 
 
The Educational status of respondents shows that out of 15 primary school certificate holders 1 
(6.6%) was coinfected; 36 were up to secondary school level with 8 (22.2%) coinfected;, 21 had 
National Diploma certificate with 1 (5.0%) positive; 61 had NCE certificate with 8 (13.1%) 
positive; 54 were university graduate with 7 (13.0%) positive, while 13 had no formal education 
with 2 (15.4%) positive (Table 4).  
 
Table 4: Educational status of HIV/TB coinfected patients attending Holley memorial hospital 
 Educ. Status No of 
respondents  
No positive  No negative  Prevalence % 
Primary school  15 1 14 6.6 
Secondary school 36 8 28 22.2 
ND 21 1 20 5.0 
NCE  61 8 53 13.1 
Uni/graduate   54 7 47 13.0 
No formal education  13 2 11 15.4 
Total  200 27 173 13.5 
X
2
 tab = 6.05; P = 0.0001; α = 0.05. 
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Occupational Distribution of TB/HIV Coinfected Patients Attending Holley Memorial 
Hospital Ochadamu 
 
On the basis of occupational status of patients showed that 10 (17.5%) were 
businessmen/women; 6 (8.2%) were public servants; 1 (9.1%) were farmers; 1 (33.3%) were 
private business owners, while 9 (16.1%) were dependent (Table 5). 
  
Table 5: Occupational distribution among TB/HIV coinfected patients attending holley memorial 
hospital ochadamu. 
Occupation No of respondents  No positive  No negative  Prevalence % 
Businessmen/women 57 10 47 17.5 
Public service 73 6 67 3.0 
Farmer  11 1 60 9.1 
Private  3 1 2 0.5 
Dependent  56 9 47 16.1 
Total  200 27 173 13.5 
X
2
 tab = 4.05; P = 0.0001; α = 0.05.   
 
Clinical Signs of TB/HIV Coinfected Patents Attending Holley Memorial Hospital 
Ochadamu 
 
Clinical sign of respondents attending Holley Memorial Hospital Ochadamu showed that 23 
(85.2%) had cough with sputum; 24 (88.9%) had dry cough; 17 (63.0%) had fever; 9 (33.3%) 
had loss of weight; 3 (11.1%) had tiredness, but of the 27 patients with loss of appetite none was 
HIV/TB coinfected (Table 6). Other symptoms of HIV or TB were not displayed by the patients. 
 
Table 6: Clinical Sign among TB/HIV Coinfected Patents Attending Holley Memorial Hospital 
Ochadamu 
Clinical signs No of respondents  No positive  No negative  Prevalence % 
Cough with sputum   27 23 4 85.2 
Drug cough  27 24 3 88.9 
Fever  27 17 10 63.0 
Weight loss  27 9 18 33.3 
Tiredness  27 3 24 11.1 
Loss of Appetite  27 0 27 0 
Chest pain 0 0 0 0 
Short breath  0 0 0 0 
Swelling of the neck 0 0 0 0 
Pneumonia  0 0 0 0 
Diarhoea  0 0 0 0 
Fungal infection of  the skin  0 0 0 0 
Night sweat  0 0 0 0 
Total  162 76 86 46.91 
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4. Discussion 
  
This study revealed a mean TB/HIV co-infection of 13.5% (Table 1). This is does not agree with 
the higher prevalence of 34.5% mean coinfection reported for Enugu State in  a similar study 
carried out by Dim (2012). At the community level, TB/ HIV transmission is more likely, and 
can substantially increase health-care costs, particularly for hospitalization to treat opportunistic 
infections and decrease productivity (Nachega et al., 2015). From table 6, there was significant 
relationship (P<0.05) between HIV/TB coinfection with clinical signs such as coughing with 
sputum and dry cough. As HIV progresses immunity declines, patients become more susceptible 
to infections such as TB, pneumonia, recurrent fungal infections of the skin and oropharynx. 
These infections can occur at any stage of progression of HIV infection and immune 
suppression. Some patients may develop constitutional symptoms (unexplained fever and weight 
loss) previously known as AIDS-related complex (ARC) or specific HIV related diseases 
occurring predominantly with severe immune suppression such as certain opportunistic 
infections (e.g. cryptococcal meningitis) and certain tumours (e.g. Kaposi sarcoma). At this late 
stage, it is sometimes known as “full-blown AIDS” (Deschamps et al., 2000; Corbette et al., 
2003).  
  
HIV increases susceptibility to infection with M. tuberculosis infection leading to TB disease. 
The risk increases with increasing immunosuppression. HIV increases not only the risk but also 
the rate of progression of recent or latent M. tuberculosis infection to diseases (Corbette et al., 
2003). 
 
The burden of tuberculosis (TB) in Nigeria is high, and unfortunately, the data from the TB 
programme of the States' ministries of health are usually unpublished, which possibly contribute 
to the prevailing ignorance and poor attitude of Nigerians to the disease (Dim and  Dim, 2013). 
In this study, TB/HIV coinfection was higher from the ages of 10 – 40 (Table 1). The prevalence 
was also higher in males than in females (Table 2). This does not agree with the observation of 
Dim and Dim (2013) in a similar study in Enugu State, who reported that the number of female 
TB cases was higher than males within the 0-14 age group only. The annual number of all TB 
cases showed a rising trend. The study therefore recommend that clinical symptoms and 
immunohaematogical indices (CD4 count, FBC and ESR) must be performed routinely to 
monitor TB and HIV patients on regular basis in order to reduce morbidity and mortality 
associated with the diseases. Future research should be conducted to identify strains of MTB in 
order to help prevent MDR cases among HIV patients.  
 
5. Conclusion 
  
TB/HIV coinfection was 13.5% among the patients as determined by sputum smear microscopy 
alone. There were significant relationships between TB and HIV status of the respondents and 
clinical symptoms (dry cough couogh with sputum, weight loss and fever). Female had more 
prevalence of TB/ HIV coinfected patients than males The highest rate of infection for both M. 
tuberculosis and HIV was among the age range of 25-69years. 
 
The findings of this study were very important and could be used in the monitoring and 
management of TB and HIV coinfection. 
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